StockNews.com assumed coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research note published on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Cellectis Stock Performance NASDAQ CLLS opened at $2.71 on Wednesday. The stock has a 50-day simple moving average of $2.77 and a 200 day simple moving […]
Investment analysts at StockNews.com assumed coverage on shares of Cellectis (NASDAQ:CLLS – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock. Cellectis Stock Performance Shares of Cellectis stock opened at $2.78 on Wednesday. The company has a quick ratio […]
Cellectis (NASDAQ:CLLS) Earns Sell Rating from Analysts at StockNews.com tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research report report published on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Cellectis Stock Up 0.6 % Shares of CLLS opened at $2.51 on Friday. The company has a debt-to-equity ratio of 0.57, a quick ratio […]
StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Cellectis Price Performance NASDAQ:CLLS opened at $2.51 on Friday. The company’s 50-day moving average price is $2.62 and its 200-day moving average price is $2.65. […]